Switch to:
More From Other Websites
Pfizer Announces Positive Top-Line Results from Pivotal Phase 3 Maintenance Trial of Oral XELJANZ®... Jul 28 2016
4:11 pm Pfizer announces top-line results from Oral Clinical Trials for tofAcitinib in ulceratiVE... Jul 28 2016
Pfizer Announces Positive Top-Line Results from Pivotal Phase 3 Maintenance Trial of Oral XELJANZ®... Jul 28 2016
Pfizer (PFE) Stock Down, Partners with Western Oncolytics on Cancer Technology Jul 28 2016
Jim Cramer: Second-Quarter Earnings Have Been Mixed Jul 28 2016
[$$] Bristol-Myers Raises Yearly Outlook Jul 28 2016
Pfizer And Western Oncolytics Reach Immuno-Oncology Research Collaboration Jul 28 2016
Pfizer and Western Oncolytics Announce Immuno-Oncology Research Collaboration to Investigate Novel... Jul 28 2016
Pfizer and Western Oncolytics Announce Immuno-Oncology Research Collaboration to Investigate Novel... Jul 28 2016
AstraZeneca helped by new drugs as cholesterol pill fades Jul 28 2016
AstraZeneca a takeover target again? CEO not commenting Jul 28 2016
[$$] Specialty-Pharma Startup Nevakar Raises $55M Jul 27 2016
Options Insight: Is Pfizer the Right Prescription? Jul 27 2016
Options Insight: Is Pfizer the Right Prescription? Jul 27 2016
[$$] Pfizer Cleared to Buy Nanotech Drug Firm Bind Therapeutics Jul 27 2016
Pfizer Reaches Initial Deal Settling Celebrex, Bextra Suits Jul 27 2016
Analyst Recommendations for Roche: Buy, Hold, or Sell? Jul 27 2016
Short Sellers Get Selective on Major Pharma Jul 27 2016
Legislator: Pfizer can't complain about execution drug Jul 26 2016


Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK